Related Experiment Videos
Androgens and bone health
1Department of Obstetrics and Gynecology, Medical College of Georgia, Augusta 30912-3360, USA.
Seminars in Reproductive Endocrinology
|August 26, 1998
Summary
Osteoporosis risk increases with age. Androgens and estrogens are vital for bone health, with androgens showing potential benefits when added to hormone replacement therapy for postmenopausal women.
Area of Science:
- Endocrinology
- Bone Biology
- Gerontology
Background:
- Osteoporosis is a prevalent metabolic bone disease, with rising incidence in aging populations.
- Hypogonadism is linked to accelerated bone loss and osteoporosis in both sexes.
- Age-related decline in adrenal and gonadal androgens affects skeletal health.
Purpose of the Study:
- To investigate the role of androgens and estrogens in bone health and osteoporosis.
- To evaluate the efficacy of androgen addition to hormone replacement therapy (HRT) in postmenopausal women.
Main Methods:
- Review of existing literature on androgen and estrogen action in bone.
- Analysis of studies examining hormone replacement therapy in postmenopausal osteoporosis.
Main Results:
- Androgens influence skeletal health through direct receptor binding or conversion to estrogens.
- Estrogen is crucial for bone remodeling, while androgens play a complex role in bone modeling and remodeling.
- Adding androgens to estrogen HRT significantly improves bone mineral density in postmenopausal females compared to estrogen alone.
Conclusions:
- Androgens are important for maintaining bone health throughout life.
- Androgen supplementation may offer significant benefits for postmenopausal osteoporosis management within HRT regimens.